DrugRisk Announces NuvaRing FDA Adverse Reports Top 5,000

The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) December 07, 2012 The DrugRisk Resource Center, a patient awareness group, is alerting women prescribed the contraceptive NuvaRing that experts have linked the devices to blood clots and the FDA has received thousands of reports of complications among users. According to the Adverse Events Report on December 5th tracking FDA AERS reports through June 30, 2012, the agency has received more than 5,000 reports
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations